Home

Nicholas Matthew Maounis

CIK 1492953 · last filed 2014-02-13

Nicholas Matthew Maounis is a corporate insider who has filed 13 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing shows the insider sold $73.0K of ACFN on Feb 13, 2014. Across all open-market trades the lifetime net is −$556.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.49M

Companies

2

Total Filings

13

Lifetime Open-Market Net

-$556.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACFN 10%+ Owner 79,288 $18.75 $1.49M -$73.7K 3 2014-02-13
Rennova Health, Inc. (TGALD) Delisted 10%+ Owner 790,319 — — -$482.9K 7 2010-08-17

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-02-13 ACFN Sell (S) −19,400 -$73.0K EDGAR
2014-02-11 ACFN Sell (S) −200 -$754 EDGAR
2013-05-14 ACFN Buy (P) — $0 EDGAR
2013-03-06 — Buy (P) +2,800 $3.6K
2011-12-20 — E — $0
2011-09-22 — Sell (S) — $0
2010-08-17 Rennova Health, Inc. (TGALD) Delisted Sell (S) −232,292 -$111.3K EDGAR
2010-07-26 Rennova Health, Inc. (TGALD) Delisted Sell (S) −110,180 -$81.3K EDGAR
2010-07-01 Rennova Health, Inc. (TGALD) Delisted Sell (S) −28,462 -$21.3K EDGAR
2010-06-25 Rennova Health, Inc. (TGALD) Delisted Sell (S) −123,156 -$95.2K EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.